Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeki Matsumoto

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Pharmacy and Pharmacology|February 26, 2004
Functional characterization of active transport of progesterone to adrenal cellsTakuo Ogihara, Shigeki Matsumoto, Shuhei Ohnishi
Physical Review Letters|February 3, 2004
Explosive dark matter annihilationJunji Hisano, Shigeki Matsumoto, Mihoko M Nojiri
Angewandte Chemie (International Ed. in English)|September 8, 2004
Formation of a stable, lattice-framework disilene: a strategy for the construction of bulky substituentsShigeki Matsumoto, Shinobu Tsutsui, Eunsang Kwon, et al.
Physical Review Letters|April 11, 2026
Torsion Balance Experiments Enable Direct Detection of Sub-eV Dark MatterShigeki Matsumoto, Jie Sheng, Chuan-Yang Xing, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizoleShigeki Matsumoto, Tomoe Hirama, Tsutomu Matsubara, et al.
Odontology|April 9, 2025
Effect of air-thinning a two-step adhesive layer on bond strength to tooth substratesYuko Nagasawa, Yoshikazu Eda, Shigeki Matsumoto, et al.
Dental Materials Journal|December 20, 2019
Characteristics of a new dental stone mixed by shakingYuko Nagasawa, Yasushi Hibino, Hirotaka Shigeta, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Studies on the metabolic fate of M17055, a novel diuretic (4): species difference in metabolic pathway and identification of human CYP isoform responsible for the metabolism of M17055Hiroyuki Nakajima, Takeshi Nakanishi, Kiyohiko Nakai, et al.
Clinical and Experimental Nephrology|November 25, 2019
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairmentYuji Kumagai, Masashi Sakaki, Kenichi Furihata, et al.
Clinical Journal of Gastroenterology|October 14, 2024
A case of MSI-high pancreatic body-tail cancer successfully treated with radical resection after pembrolizumabMiki Ito, Toru Watanabe, Yoko Oga, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Pharmacy and Pharmacology|February 26, 2004
Functional characterization of active transport of progesterone to adrenal cellsTakuo Ogihara, Shigeki Matsumoto, Shuhei Ohnishi
Physical Review Letters|February 3, 2004
Explosive dark matter annihilationJunji Hisano, Shigeki Matsumoto, Mihoko M Nojiri
Angewandte Chemie (International Ed. in English)|September 8, 2004
Formation of a stable, lattice-framework disilene: a strategy for the construction of bulky substituentsShigeki Matsumoto, Shinobu Tsutsui, Eunsang Kwon, et al.
Physical Review Letters|April 11, 2026
Torsion Balance Experiments Enable Direct Detection of Sub-eV Dark MatterShigeki Matsumoto, Jie Sheng, Chuan-Yang Xing, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 19, 2002
Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizoleShigeki Matsumoto, Tomoe Hirama, Tsutomu Matsubara, et al.
Odontology|April 9, 2025
Effect of air-thinning a two-step adhesive layer on bond strength to tooth substratesYuko Nagasawa, Yoshikazu Eda, Shigeki Matsumoto, et al.
Dental Materials Journal|December 20, 2019
Characteristics of a new dental stone mixed by shakingYuko Nagasawa, Yasushi Hibino, Hirotaka Shigeta, et al.
Drug Metabolism and Pharmacokinetics|December 25, 2004
Studies on the metabolic fate of M17055, a novel diuretic (4): species difference in metabolic pathway and identification of human CYP isoform responsible for the metabolism of M17055Hiroyuki Nakajima, Takeshi Nakanishi, Kiyohiko Nakai, et al.
Clinical and Experimental Nephrology|November 25, 2019
Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairmentYuji Kumagai, Masashi Sakaki, Kenichi Furihata, et al.
Clinical Journal of Gastroenterology|October 14, 2024
A case of MSI-high pancreatic body-tail cancer successfully treated with radical resection after pembrolizumabMiki Ito, Toru Watanabe, Yoko Oga, et al.
Pageof 2